Tardive and withdrawal dyskinesia associated with haloperidol. 1974

G Jacobson, and R J Baldessarini, and T Manschreck

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009069 Movement Disorders Syndromes which feature DYSKINESIAS as a cardinal manifestation of the disease process. Included in this category are degenerative, hereditary, post-infectious, medication-induced, post-inflammatory, and post-traumatic conditions. Dyskinesia Syndromes,Etat Marbre,Status Marmoratus,Movement Disorder Syndromes,Dyskinesia Syndrome,Movement Disorder,Movement Disorder Syndrome
D011618 Psychotic Disorders Disorders in which there is a loss of ego boundaries or a gross impairment in reality testing with delusions or prominent hallucinations. (From DSM-IV, 1994) Psychoses,Psychosis, Brief Reactive,Schizoaffective Disorder,Schizophreniform Disorders,Psychosis,Brief Reactive Psychoses,Brief Reactive Psychosis,Disorder, Psychotic,Disorder, Schizoaffective,Disorder, Schizophreniform,Disorders, Psychotic,Disorders, Schizoaffective,Disorders, Schizophreniform,Psychoses, Brief Reactive,Psychotic Disorder,Reactive Psychoses, Brief,Reactive Psychosis, Brief,Schizoaffective Disorders,Schizophreniform Disorder
D002090 Butyrophenones Compounds containing phenyl-1-butanone.
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D005260 Female Females
D006220 Haloperidol A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279) Haldol
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths

Related Publications

G Jacobson, and R J Baldessarini, and T Manschreck
May 1982, The American journal of psychiatry,
G Jacobson, and R J Baldessarini, and T Manschreck
August 1985, The Journal of clinical psychiatry,
G Jacobson, and R J Baldessarini, and T Manschreck
December 1979, The British journal of psychiatry : the journal of mental science,
G Jacobson, and R J Baldessarini, and T Manschreck
February 2011, Indian journal of pharmacology,
G Jacobson, and R J Baldessarini, and T Manschreck
January 1987, Biological psychiatry,
G Jacobson, and R J Baldessarini, and T Manschreck
November 1976, Psychopharmacology,
G Jacobson, and R J Baldessarini, and T Manschreck
October 1978, Psychopharmacology,
G Jacobson, and R J Baldessarini, and T Manschreck
April 1973, The American journal of psychiatry,
G Jacobson, and R J Baldessarini, and T Manschreck
January 1983, Progress in neuro-psychopharmacology & biological psychiatry,
G Jacobson, and R J Baldessarini, and T Manschreck
February 1984, British medical journal (Clinical research ed.),
Copied contents to your clipboard!